In Depth 25 Jan 2024 The trends that will shape the biotech industry in 2024 …mingled with other metabolic diseases, GLP-1 drugs will replace Lipitors. Furthermore, scientific findings about mitochondria are exciting as they show it is related to many diseases and complications. Aging relates… January 25, 2024 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2024 Booster launches to treat neurodegenerative diseases with proteasome activation …aggregated proteins. This strategy is particularly important for diseases where multiple proteinopathies – conditions caused by the accumulation of malfunctioning proteins – are present simultaneously, as seen in neurodegenerative diseases… October 15, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2017 Top European VC and CRO fund Young Metabolic Disease Biotech …in Berlin focusing on the treatment of metabolic diseases. The company has now raised €8M in Series A, led by Scottish biotech VC Epidarex Capital. Among the investors was also… January 9, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jan 2020 AstraZeneca Recruits RNA Biotech to Develop Metabolic Disease Therapies The UK biotech MiNA Therapeutics has launched a collaboration with AstraZeneca to develop small activating RNA drugs, which could treat metabolic diseases using targets unreachable by current medications. According to… January 7, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2025 GLP-1 drugs on WHO Essential Medicines List: what’s the impact? …as cardiovascular diseases or chronic kidney diseases. Semaglutide works like any GLP-1 agonist. GLP-1 is a hormone that is produced by the proglucagon gene in cells of the small intestine…. September 19, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 19 Jun 2017 This Company Uses the Human Microbiome to Discover New Disease Mechanisms …role in health and also cause unprecedented damage by starting inflammatory cascades, leading to numerous metabolic diseases. Finding the Link And so, while everybody else was focusing on the human… June 19, 2017 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Nov 2024 Six antisense oligonucleotide companies shaping the future of genetic medicine …that TGF-β is chronically elevated in many diseases, including ophthalmic and fibrotic diseases and cancer, and involved in their pathophysiology, it is thought to be an extremely versatile drug target… November 28, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 28 Feb 2023 What’s happening on Rare Disease Day? …are recent advancements in rare diseases? “There are more than 8,000 known rare diseases that affect over 300 million people globally. Yet only a small percentage of these have treatments… February 28, 2023 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 10 Sep 2025 When rare diseases are not so rare after all: A closer look at where and why this happens …impact of these diseases and, in certain areas or communities around the world, some diseases that are considered rare globally are actually much more prevalent. With most rare diseases being… September 10, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Opinion 11 Jul 2022 Precision medicine: the next big leap for metabolic disorders …metabolic syndrome endotype requires operating at the molecular level. Other than a few rare genetic diseases, metabolic syndrome endotypes cannot be understood by looking purely at genetic mutations in the… July 11, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 20 Feb 2018 A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs …genetic metabolic diseases, and a group of Swiss investors based in Lugano, Switzerland, including TiVenture – no financial data for the deal was disclosed. Gain Therapeutics is looking to apply… February 20, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Sep 2024 Six biotech companies that could revolutionize obesity treatments …numerous investigational drugs to treat cancer, autoimmune diseases, and metabolic diseases like diabetes and obesity. The two notable obesity drugs of the company are HRS9531, a dual agonist of GLP-1/GIP… September 5, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email